In today’s recent session, 0.58 million shares of the Ensysce Biosciences Inc (NASDAQ:ENSC) have been traded, and its beta is 1.18. Most recently the company’s share price was $2.18, and it changed around $0.22 or 11.48% from the last close, which brings the market valuation of the company to $3.76M. ENSC at last check was trading at a discount to its 52-week high of $14.67, offering almost -572.94% off that amount. The share price’s 52-week low was $1.70, which indicates that the recent value has risen by an impressive 22.02% since then. We note from Ensysce Biosciences Inc’s average daily trading volume that its 10-day average is 90090.0 shares, with the 3-month average coming to 41.40K.
Ensysce Biosciences Inc (NASDAQ:ENSC) trade information
Instantly ENSC has been showing a green trend so far today with a performance of 11.48% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.1200 on recent trading daydecreased the stock’s daily price by -2.83%. The company’s shares are currently down -73.16% year-to-date, but still up 17.47% over the last five days. On the other hand, Ensysce Biosciences Inc (NASDAQ:ENSC) is -43.97% down in the 30-day period. We can see from the shorts that 31447.0 shares have been sold at a short interest cover period of 1.62 day(s).
Ensysce Biosciences Inc (ENSC) estimates and forecasts
The year-over-year growth rate is expected to be -100.00%, down from the previous year.
The company’s sales for the same quarters a year ago were 305.72k and 181.8k respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -100.00%. Forecasts for the next quarter put sales growth at -100.00%.
ENSC Dividends
Ensysce Biosciences Inc’s next quarterly earnings report is expected to be released on 2025-Mar-09.
Ensysce Biosciences Inc (NASDAQ:ENSC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.63% of Ensysce Biosciences Inc shares, and 8.56% of them are in the hands of institutional investors. The stock currently has a share float of 8.62%. Ensysce Biosciences Inc stock is held by 8.0 institutions, with PLANTE MORAN FINANCIAL ADVISORS, LLC being the largest institutional investor. By 2024-06-30, it held 0.0004% of the shares, which is about 20.0 shares worth $10.0.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 6.08 shares worth $13061.0, making up 0.43% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 1.34 shares worth around $2874.0, which represents about 0.10% of the total shares outstanding.
